[Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease].

[1]  S. Bakri,et al.  Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[2]  S. Ozdek,et al.  Photodynamic therapy for best disease complicated by choroidal neovascularization in children. , 2011, Journal of pediatric ophthalmology and strabismus.

[3]  J. Sahel,et al.  Traitement par injection intravitréenne de bevacizumab de néovaisseaux choroïdiens compliquant une maladie de Best , 2011 .

[4]  M. Parodi,et al.  Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy. , 2010, Investigative ophthalmology & visual science.

[5]  E. Souied,et al.  Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy , 2008, Acta ophthalmologica.

[6]  N. Schrage,et al.  Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumab , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  E. Stone,et al.  VISUAL OUTCOME FOLLOWING SUBRETINAL HEMORRHAGE IN BEST DISEASE , 2001, Retina.

[8]  G. Fishman,et al.  Visual acuity in patients with best vitelliform macular dystrophy. , 1993, Ophthalmology.

[9]  D. M. Gass,et al.  Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment , 1987 .

[10]  J. Sahel,et al.  [Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease]. , 2011, Journal francais d'ophtalmologie.

[11]  P. Liao,et al.  Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment , 1987, The Yale Journal of Biology and Medicine.